News about pandemic - ICAV International Consortium on Anti-Virals

News

Canada must address the global antiviral deficit

Read more

Health Canada approves isoquercetin COVID-19 trial – ICAV network 2nd trial

Read more

Isoquercetin Clinical Trial Application Submitted to Health Canada

Read more

Pandemics: A Global Threat

Read more

Drug Development Process

Read more

Clinical Trial Process

Read more

Jeremy Carver PhD | President and CEO

© ICAV 2020.

Created by MtoM Création

logo-the-international-consortium-on-anti-virals-icav-canada

Contact